Final results of a phase II study of nivolumab in Japanese patients with relapsed or refractory classical Hodgkin lymphoma

BACKGROUND: Many patients with classical Hodgkin lymphoma show increased programmed death-1 ligand expression in Reed–Sternberg cells. We report the final results of a phase II study of nivolumab, an anti-programmed death-1 monoclonal antibody, in Japanese patients with relapsed or refractory classi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Jpn J Clin Oncol
Autors principals: Maruyama, Dai, Terui, Yasuhito, Yamamoto, Kazuhito, Fukuhara, Noriko, Choi, Ilseung, Kuroda, Junya, Ando, Kiyoshi, Hattori, Akira, Tobinai, Kensei
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2020
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7579338/
https://ncbi.nlm.nih.gov/pubmed/32776097
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jjco/hyaa117
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars